Our blog

Subcutaneous levodopa infusion pump in advanced Parkinson

14 de November de 2019

The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa,…

Compartir:
Posted in: Uncategorized

Biogen will request the approval to FDA of a new drug in early Alzheimer’s disease.

12 de November de 2019

  On October 22, 2019, Biogen announced the positive result of its EMERGE clinical trial…

Compartir:
Posted in: News

The General University Hospital of Catalonia, a reference in Alzheimer’s research

5 de November de 2019

Neurology and Neuropsychology team specializes in the evaluation of biomarkers and the early diagnosis of…

Compartir:
Posted in: Uncategorized

A new algorithm allows to identify the people with more Alzheimer’s risk

5 de November de 2019

The Pasqual Maragall Foundation develops a method based on magnetic resonance imaging It allows to…

Compartir:
Posted in: Uncategorized

New clinical trials are looking for a cure to avoid 100 million of new patients in 2050.

25 de October de 2019

The General University Hospital of Catalonia analyzes in two proteins and in a gum bacterium…

Compartir:

We started an intravenous antiamyloid therapy in mild Alzheimer’s

20 de September de 2019

Our team participated in a phase II clinical trial, with an antiamyloid monoclonal antibody in…

Compartir:
Posted in: Uncategorized

Dental infection and Alzheimer’s disease

6 de September de 2019

We have initiated a clinical trial to assess the efficacy and safety of a drug…

Compartir:
Posted in: Alzeimer, Alzeimer, Alzeimer

Progressive Supranuclear Paralysis (PSP): An Innovative Therapy

19 de July de 2019

We have been selected to evaluate an innovative therapy in this terrible disease. We will…

Compartir:

Another terapeutic target in Alzheimer disease

9 de May de 2019

We started a phase II / III trial with an inhibitor of TAU protein aggregation…

Compartir:
Posted in: Uncategorized

Novel contribution to the treatment of motor fluctuations in Parkinson’s

27 de March de 2019

New formulation of combined action Levodopa We have started the evaluation of a new preparation…

Compartir:

New antidiskinetic therapy in Parkinson’s disease

20 de March de 2019

We have started a clinical trial with a new antidiskinetic therapy (combination of two drugs…

Compartir:
Posted in: Uncategorized

Advanced Parkinson’s disease treated with a levodopa pump

20 de March de 2019

The UDIC will shortly begin a clinical trial to evaluate the subcutaneous administration of levodopa,…

Compartir:
Posted in: Uncategorized
Page 2 of 3 1 2 3

Compartir: